Brain Stimulation for Episodic Memory Improvement
(BNI Trial)
Trial Summary
What is the purpose of this trial?
Brain stimulation is a means to potentially remediate symptoms in a range of neurological and psychiatric diseases, however, precise targeting of stimulation is necessary to ensure efficacy. The proposed project will use recent advances in functional magnetic resonance imaging to delineate distributed brain networks within individuals, and use these network maps to guide selection of intracranial electrodes for stimulation during an episodic memory task. The resulting data will refine the current understanding of the neural systems involved in episodic memory, and provide a proof-of-principle for the use of individual-level network mapping to guide brain stimulation, which could have important implications for brain stimulation therapies for a range of mental health disorders.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of this treatment for improving memory?
Research shows that transcranial electrical stimulation (tES) can enhance memory in older individuals, with effects lasting up to 28 days after a single session. Additionally, neurostimulation methods like tES and transcranial magnetic stimulation (TMS) are being explored for memory enhancement in epilepsy patients, suggesting potential benefits for memory improvement.12345
Is brain stimulation safe for humans?
How does brain stimulation differ from other treatments for memory improvement?
Brain stimulation, such as Transcranial Magnetic Stimulation (TMS) and Transcranial Electrical Stimulation (TES), is unique because it directly targets specific brain areas to enhance memory, unlike other treatments that may not focus on the brain's electrical activity. This approach can modulate brain activity in real-time, potentially improving memory performance by enhancing the brain's natural processes.211121314
Research Team
Rodrigo M Braga, PhD
Principal Investigator
Northwestern University
Eligibility Criteria
This trial is for adult epilepsy patients at Northwestern Memorial Hospital who are undergoing routine presurgical planning with intracranial EEG, which includes electrode placement in specific brain regions. It's not for minors, pregnant women, prisoners, those unable to consent, or anyone with MRI contraindications like metal implants.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-surgical fMRI Mapping
Participants undergo 1 to 4 sessions of fMRI to map brain networks before surgical implantation of electrodes
Post-surgical Monitoring and Experimentation
Participants are monitored post-surgery and participate in experiments involving intracranial electroencephalography and electrical brain stimulation
Follow-up
Participants are monitored for safety and effectiveness after the experimental procedures
Treatment Details
Interventions
- Brain stimulation
Brain stimulation is already approved in United States, European Union, Canada for the following indications:
- Treatment-resistant depression (TRD)
- Treatment-resistant depression (TRD)
- Obsessive-compulsive disorder (OCD)
- Severe depression
- Bipolar disorder
- Schizophrenia
- Treatment-resistant depression (TRD)
- Treatment-resistant depression (TRD)
- Obsessive-compulsive disorder (OCD)
- Severe depression
- Bipolar disorder
- Schizophrenia
- Treatment-resistant depression (TRD)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Northwestern University
Lead Sponsor